Epidemiology of Atopic Dermatitis: Recent Advances and Future Predictions

Author(s):  
H.C. Williams
2014 ◽  
Vol 32 (No. 3) ◽  
pp. 205-212 ◽  
Author(s):  
A. Patel ◽  
N. Shah

Food allergy is an adverse immune response to some proteins in some foods. Probiotic, health promoting bacteria have gained much importance because of their innumerable benefits, particularly in the treatment of diarrhea, hypercholesterolemia, atopic dermatitis, eczema, and gastrointestinal disorders by strengthening the immune system. The current paper reviews recent advances made in the treatment of food allergy through employing probiotic or synbiotic therapy. The results of several reports are very promising suggesting probiotics can influence the immune system to curtail the allergic responses.


2008 ◽  
Vol 2 (6) ◽  
pp. 733-747 ◽  
Author(s):  
Joseph Lam ◽  
Sheila F Friedlander

2021 ◽  
Vol 22 (24) ◽  
pp. 13655
Author(s):  
Oliver Massey ◽  
Cenk Suphioglu

The IL-4 and IL-13 cytokine pathways play integral roles in stimulating IgE inflammation, with the IL-4 cytokine being a major cytokine in the etiology of thunderstorm asthma, atopic dermatitis, and allergic rhinitis. The increasing prevalence of thunderstorm asthma in the younger population and the lessening efficacy of corticosteroids and other anti-inflammatories has created a need for more effective pharmaceuticals. This review summarizes the IL-4 and IL-13 pathways while highlighting and discussing the current pathway inhibitors aimed at treating thunderstorm asthma and atopic dermatitis, as well as the potential efficacy of peptide therapeutics in this field.


2018 ◽  
Vol 120 (1) ◽  
pp. 8-9
Author(s):  
Chitra Dinakar ◽  
Stanley M. Fineman ◽  
Stephen A. Tilles

2020 ◽  
Vol 66 ◽  
pp. 14-21 ◽  
Author(s):  
Kangmo Ahn ◽  
Byung Eui Kim ◽  
Jihyun Kim ◽  
Donald YM Leung

2021 ◽  
Vol 0 ◽  
pp. 1-5
Author(s):  
Ramkumar Ramamoorthy

Atopic dermatitis (AD) is a chronic skin disorder resulting from complex interactions between skin barrier defects and a dysregulated immune system, marked by activation of multiple T cell subsets at different stages of the disease. Until recently, the management of AD rested mainly on the judicious use of emollients, topical steroids, and topical calcineurin inhibitors in the majority of patients and systemic immunosuppressants were advocated in severely diseased. However, in the last few years, new therapeutic strategies were designed and developed to target the various steps in the chain of molecular events that lead to the AD phenotype. This review article will focus on the recent advances in the management of AD.


Drugs ◽  
2004 ◽  
Vol 64 (23) ◽  
pp. 2639-2666 ◽  
Author(s):  
Thomas Christian Roos ◽  
Stefan Geuer ◽  
Sabine Roos ◽  
Harald Brost

Author(s):  
Zahid Hussain ◽  
Shariza Sahudin ◽  
Hnin Ei Thu ◽  
Ahmad Nazrun Shuid ◽  
Syed Nasir Abbas Bukhari ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document